OSA digital network for early diagnosis and monitoring
Part of Brain & nervous system, Lungs & breathing clinical trials.
This trial tests a digital tool to help diagnose and monitor obstructive sleep apnea earlier. It may help people with sleep apnea get better care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with obstructive sleep apnea
- You are 18 years or older
- You are able to sign a consent form
- You agree to participate in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well current and new devices can diagnose obstructive sleep apnea (OSA). You may help researchers find more accurate and easier ways to detect breathing problems during sleep.
This study tests new ways to diagnose obstructive sleep apnea. If you haven't been diagnosed with sleep apnea and are generally healthy, you may be able to join.
This trial tests whether a special computer model can predict sleep apnea severity using a stethoscope and a fingertip oxygen sensor, instead of a full sleep test. It might help people get faster and easier sleep apnea diagnosis.
This trial tests a program that helps you manage sleep apnea on your own. It is for people who were recently diagnosed, are not very active, and are just beginning or thinking about starting breathing device treatment.
This trial tests a new home-based sleep monitor that goes under your mattress. It may help people with obstructive sleep apnea who are using a mouthpiece (MAD) as treatment.
This trial is testing an under-mattress device called Sleeptracker-AI to see how well it measures heart rate, breathing, and sleep patterns. It may help people with suspected sleep apnoea get easier sleep monitoring at home.
Hear when a new OSA - Obstructive Sleep Apnea trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.